跳至主要内容
临床试验/NCT00572351
NCT00572351已完成不适用

The Effects of Red Wine and White Wine on Blood Estrogen and Progesterone Levels

Cedars-Sinai Medical Center2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2006年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
2
主要终点
blood estrogen and progesterone levels

研究概览

简要总结

Healthy pre-menopausal women will be recruited in order to test the effects of red wine and white wine on blood estrogen and progesterone levels. The women will be randomized and rotated through two different treatments (red wine, white wine). Estrone and estradiol are hormones in the category of estrogens. It is known that the bodies of both men and women may convert (or aromatize) a certain amount of naturally occurring testosterone into estrogen. Aromatase inhibitors have been used to prevent this conversion, or aromatization, of testosterone into estrogen, in the treatment of estrogen-dependent breast cancer in women. This inhibition leads to a marked decrease in estrogen (estradiol and estrone) levels. Naturally occurring aromatase inhibitors include grapes, grape juice, and red, but not white wine. The aromatase inhibitory effects are attributed to wine phytochemicals and not to alcohol. Based upon this information, the investigators will monitor the estrogen levels at various phases in the menstrual cycles of women since hormone levels naturally vary throughout the menstrual cycle. Several epidemiologic studies have found that there is a correlation with moderate to high levels of alcohol consumption and breast cancer. Therefore, study participants will be asked to drink only a eight ounces of wine which should have minimal or no risk for the development of breast cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pre-menopausal with regular ovulatory cycles for 12 months prior to the study
  • willingness and ability to participate in study requiring alcohol consumption
  • in general good health
  • BMI of 18.5-35
  • on regular, unrestricted diet
  • not currently, or within the past 3 months, using oral contraceptives or other hormone replacement therapy

排除标准

  • irregular menstrual cycles or vasomotor symptoms within the last 12 months
  • pregnant (or breast feeding)
  • any hormone therapy including phytoestrogens, oral contraceptives, SERMs (selective estrogen receptor modulators), or androgens (or precursors) for three months prior to the study
  • history of alcohol abuse
  • history of any estrogen-dependent neoplasia
  • high intake of dietary soy products
  • Minors < age 21 years

研究组 & 干预措施

Red Wine

Active Comparator

干预措施: Red Wine (Other)

White Wine

Active Comparator

干预措施: White Wine (Other)

结局指标

主要结局

blood estrogen and progesterone levels

时间窗: 15 minutes

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Noel Bairey Merz

Director of the Barbra Streisand Women's Heart Center at Cedars-Sinai Medical Center

Cedars-Sinai Medical Center

研究点 (2)

Loading locations...

相似试验